We are currently investigating intermittent issues affecting access to some articles and pages on our site. We apologize for any inconvenience and are working to resolve this as quickly as possible.

10 Most Popular Funds in Sep 2017 (Offshore Funds)

10 Most Searched for Offshore Funds by tw.morningstar.com users

Morningstar Editors 20 October, 2017 | 9:00
Facebook Twitter LinkedIn

 

1. AB FCP I - Global High Yield Portfolio AT Inc
Morningstar Category: Global High Yield Bond
Morningstar Rating (2017-09-30): Stars 3

2. Templeton Emerging Markets Bond Fund A(Mdis)USD
Morningstar Category: Global Emerging Markets Bond
Morningstar Rating (2017-09-30): Stars 3

3. Allianz Global Investors Fund - Allianz Income and Growth AM USD
Morningstar Category: USD Moderate Allocation
Morningstar Rating (2017-09-30): Stars 5

4. Templeton Global Total Return Fund A(Mdis)USD
Morningstar Category: Global Bond
Morningstar Rating (2017-09-30): Stars 5

5. BlackRock Global Funds - World Mining Fund A2
Morningstar Category: Sector Equity Natural Resources
Morningstar Rating (2017-09-30): Stars 2

6. UBS (Lux) Equity Fund - Biotech (USD) P-acc
Morningstar Category: Sector Equity Biotechnology
Morningstar Rating (2017-09-30): Stars 4

7. AB FCP I - Global High Yield Portfolio AA USD Inc
Morningstar Category: Global High Yield Bond
Morningstar Rating (2017-09-30): Stars 3

8. Morgan Stanley Investment Funds US Advantage Fund A
Morningstar Category: US Large-Cap Growth Equity
Morningstar Rating (2017-09-30): Stars 5

9. MFS® Meridian Funds - European Research Fund A1 EUR
Morningstar Category: Europe Large-Cap Blend Equity
Morningstar Rating (2017-09-30): Stars 5

10. Franklin Biotechnology Discovery Fund A(acc)USD
Morningstar Category: Sector Equity Biotechnology
Morningstar Rating (2017-09-30): Stars 4

 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. 

 

 

Facebook Twitter LinkedIn

About Author

Morningstar Editors  -

© Copyright 2024 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy         Disclosures